Water-for-Injection loop upgraded
Ergopharm has expanded and re-qualified the Water-for-Injection (WFI) generation and distribution loop serving its sterile injectables suite at the Ergopharm Advanced Research Centre in Vadodara. The upgraded system raises available capacity for aseptic filling and reinforces the pharmaceutical-water controls that underpin every parenteral batch.
WFI is the highest-grade pharmaceutical water Ergopharm produces and the foundation of its sterile-injectables operation, used both as a formulation component and for final rinsing of product-contact surfaces. The upgraded loop increases generation output and extends the distribution ring so that additional filling and preparation points can be served simultaneously, easing a constraint that previously limited how many aseptic activities could run in parallel.
“Circulated hot and continuously, with no dead legs, the extended loop is designed to deliver Water-for-Injection to specification at every point of use.”
The distribution loop retains the design principles that keep WFI within specification in continuous service: it is maintained hot and kept in constant turbulent circulation, with no dead legs where water could stagnate, so that every user point draws from the same controlled, self-sanitising stream. The extended ring and additional take-off points were built to the same standard, and the whole system was subjected to a fresh qualification exercise before being returned to routine use.
Re-qualification followed the established Installation, Operational and Performance Qualification (IQ/OQ/PQ) sequence. The performance phase in particular ran over an extended period to demonstrate that every point of use consistently meets the compendial requirements for WFI across daily and seasonal operating conditions. Sampling and release remain governed by Ergopharm's routine monitoring programme, with results recorded under ALCOA+ data-integrity principles and reviewed as part of the site's ongoing utility oversight.
The upgrade sits within the framework introduced by the revised EU GMP Annex 1 for sterile products, which came into force in August 2023 and places renewed emphasis on the design, qualification and continuous monitoring of critical utilities such as WFI. For Ergopharm the practical benefits are threefold: more headroom to schedule aseptic filling, a distribution network engineered to keep water quality stable at every draw point, and a documented qualification trail that supports the traceability and quality assurance the company applies to each prescription batch it manufactures for export.
Key facts
- Utility
- Water-for-Injection (WFI) generation and distribution loop
- Qualification
- Re-qualified through IQ/OQ/PQ, with an extended PQ monitoring phase
- Governing standard
- EU GMP Annex 1 (sterile products), in force 25 Aug 2023
- Practical benefit
- Added aseptic-filling capacity and consistent WFI quality at every point of use